kras mutation and glutathion glynac G12 mutant alleles differentially control glutamine metabolism via FOXO1 Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




